loadpatents
name:-0.012935161590576
name:-0.014846086502075
name:-0.017428874969482
Prilenia Neurotherapeutics Ltd. Patent Filings

Prilenia Neurotherapeutics Ltd.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Prilenia Neurotherapeutics Ltd..The latest application filed is for "use of pridopidine for the treatment of fragile x syndrome".

Company Profile
39.22.38
  • Prilenia Neurotherapeutics Ltd. - Herzliya IL
  • PRILENIA NEUROTHERAPEUTICS LTD. -
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
High concentration dosage forms of pridopidine
Grant 11,452,694 - Licht , et al. September 27, 2
2022-09-27
Method of treating amyotrophic lateral sclerosis with pridopidine
Grant 11,406,625 - Geva , et al. August 9, 2
2022-08-09
Use Of Pridopidine For The Treatment Of Fragile X Syndrome
App 20220202798 - HAYDEN; Michael ;   et al.
2022-06-30
Low Dose Pridopidine For Parkinson's Disease And Other Diseases Associated With Parkinsonism
App 20220193059 - HAYDEN; Michael ;   et al.
2022-06-23
Treatment Of Neurodegenerative Eye Disease Using Pridopidine
App 20220062255 - Geva; Michal ;   et al.
2022-03-03
Use of pridopidine for the treatment of fragile X syndrome
Grant 11,234,973 - Hayden , et al. February 1, 2
2022-02-01
Analogs Of Pridopidine, Their Preparation And Use
App 20220023280 - SCHMIDT; Malle ;   et al.
2022-01-27
Pharmaceutical compositions for combination therapy
Grant 11,207,308 - Waters , et al. December 28, 2
2021-12-28
Use of pridopidine for treating functional decline
Grant 11,207,310 - Hayden , et al. December 28, 2
2021-12-28
Analogs of pridopidine, their preparation and use
Grant 11,141,412 - Schmidt , et al. October 12, 2
2021-10-12
Pridopidine For Treating Huntington's Disease
App 20210308115 - Bassan; Merav ;   et al.
2021-10-07
Pridopidine For Treating Drug Induced Dyskinesias
App 20210275512 - GEVA; Michal ;   et al.
2021-09-09
Pridopidine for treating huntington's disease
Grant 11,090,297 - Bassan , et al. August 17, 2
2021-08-17
Pridopidine For The Treatment Of Mitochondrial-associated Diseases And Disorders And Endoplasmic Reticulum (er) Stress
App 20210220342 - HAYDEN; Michael ;   et al.
2021-07-22
Pridopidine for treating drug induced dyskinesias
Grant 11,000,519 - Geva , et al. May 11, 2
2021-05-11
Use Of Pridopidine For The Treatment Of Anxiety And Depression
App 20210106572 - GEVA; Michal ;   et al.
2021-04-15
Use Of Pridopidine For The Treatment Of Anxiety And Depression
App 20210093622 - HAYDEN; Michael ;   et al.
2021-04-01
Use Of Pridopidine For Treating Functional Decline
App 20210052560 - Hayden; Michael ;   et al.
2021-02-25
Method Of Treating Amyotrophic Lateral Sclerosis With Pridopidine
App 20210030734 - GEVA; Michal ;   et al.
2021-02-04
Deuterated analogs of pridopidine useful as dopaminergic stabilizers
Grant 10,799,492 - Sonesson October 13, 2
2020-10-13
High Concentration Dosage Forms Of Pridopidine
App 20200188305 - LICHT; Danit ;   et al.
2020-06-18
Method Of Treating Amyotrophic Lateral Sclerosis With Pridopidine
App 20200179355 - GEVA; Michal ;   et al.
2020-06-11
Use of pridopidine to improve cognitive function and for treating Alzheimer's disease
Grant 10,603,311 - Geva , et al.
2020-03-31
Use Of Pridopidine To Improve Cognitive Function And For Treating Alzheimer's Disease
App 20200093813 - Geva; Michal ;   et al.
2020-03-26
Analogs Of Pridopidine, Their Preparation And Use
App 20200030308 - SCHMIDT; Malle ;   et al.
2020-01-30
Pharmaceutical Compositions For Combination Therapy
App 20200000785 - Waters; Ross Nicholas ;   et al.
2020-01-02
Pridopidine For Treating Drug Induced Dyskinesias
App 20190350914 - GEVA; Michal ;   et al.
2019-11-21
Pridopidine For Treating Huntington's Disease
App 20190350915 - BASSAN; Merav ;   et al.
2019-11-21
Use Of Pridopidine For The Treatment Of Fragile X Syndrome
App 20190336488 - HAYDEN; Michael ;   et al.
2019-11-07
Analogs of pridopidine, their preparation and use
Grant 10,406,145 - Schmidt , et al. Sept
2019-09-10

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed